-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on HCA Healthcare, Lowers Price Target to $475

Benzinga·07/28/2026 12:12:44
語音播報
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $525 to $475.